Ross AP, Besser C, Stoneman S, Gaunt H, Barker N
Data from a large retrospective cohort study to be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough Meeting showed that GLP-1 receptor agonist (GLP-1 RA) use was significantly associated with lower colorectal cancer incidence among patients with inflammatory bowel disease (IBD), including those with comorbid type 2 diabetes (T2D)
Short follow-up periods may not capture potential safety issues associated with long-term use, thereby increasing the unknown risks to the long-term health of pediatric patients
Finally, the nicotinic acid moiety in NaAD is amidated to a nicotinamide (Nam) moiety, forming nicotinamide adenine dinucleotide
Causes Mutations in the SLC25A20 gene cause CACT deficiency
Conversely, BPC157s prowess in gastrointestinal health and wound healing offers a broader spectrum of potential benefits